Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2A Study of Ifenprodil in Severe COVID-19 Pneumonia
KCT0005307Phase 2Recruiting
- Sponsor
- Dong-A University Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifenprodil in coronavirus disease 2019 (COVID-19), pneumonia, sponsored by Dong-A University Hospital. Started Sep 2020; status: recruiting.
02
Drugs
ifenprodil
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on KCT0005307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005307.